Blog
RSS FeedPosted by Michael Wonder on 15 Jul 2016
Gilead receives approval in Canada for Epclusa (sofosbuvir/velpatasvir), the first once-daily pan-genotypic (genotypes 1-6) single tablet regimen for the treatment of chronic hepatitis C
14 July 2016 - Two week treatment with Epclusa provides high cure rates for all six hepatitis C genotypes. ...
Posted by Michael Wonder on 13 Jul 2016
Pfizer receives FDA approval for Prevnar 13 in adults age 18 through 49
12 July 2016 - Prevnar 13 is the only pneumococcal vaccine approved in the U.S. for patients 6 weeks through adulthood. ...
Posted by Michael Wonder on 12 Jul 2016
Degarelix acetate: the prostate cancer lifeline drug finally approved after three-year wait
12 July 2016 - Thousands of men suffering from advanced prostate cancer have been thrown a lifeline after a drug that ...
Posted by Michael Wonder on 12 Jul 2016
NICE draft guidance extends treatment options for thousands of people with severe rheumatoid arthritis
12 July 2016 - New draft guidance from NICE means thousands of people suffering with severe rheumatoid arthritis will have more ...
Posted by Michael Wonder on 12 Jul 2016
FDA approves new medication for dry eye disease
12 July 2016 - The U.S. FDA approved Xiidra (lifitegrast ophthalmic solution) for the treatment of signs and symptoms of dry ...
Posted by Michael Wonder on 12 Jul 2016
Tagrisso (osimertinib mesylate) approved by Health Canada as treatment for patients with locally advanced or metastatic EGFR T790M mutation-positive non-small cell lung cancer
1 July 2016 - A result of one of the fastest development programs from start of clinical trials to regulatory approval. ...
Posted by Michael Wonder on 11 Jul 2016
SMC gives green light for BMS’ Opdivo
11 July 2016 - Scotland will be first UK country to access the drug after NICE refusal. ...
Posted by Michael Wonder on 11 Jul 2016
SMC - July 2016 decisions
11 July 2016 - Two new medicines for lung cancer among five treatments accepted for routine use in NHS Scotland. ...
Posted by Michael Wonder on 11 Jul 2016
FDA approves first and only single monthly injection for a PCSK9 inhibitor
10 July 2016 - Repatha (evolocumab) Pushtronex system available to U.S. patients in early August. ...
Posted by Michael Wonder on 11 Jul 2016
FDA approves first MRI-guided focused ultrasound device to treat essential tremor
11 July 2016 - The U.S. FDA today approved the first focused ultrasound device to treat essential tremor in patients who ...
Posted by Michael Wonder on 08 Jul 2016
EMA publishes EPAR for Odefsey (emtricitabine with rilpivirine hydrochloride and tenofovir alafenamide fumarate)
8 July 2016 - The EMA has published an EPAR for Gilead Sciences' Odefsey. ...
Posted by Michael Wonder on 08 Jul 2016
FDA approves first HPV test for use with SurePath Preservative Fluid
7 July 2016 - The U.S. FDA today approved the Roche cobas HPV Test as the first test for human papilloma ...
Posted by Michael Wonder on 08 Jul 2016
FDA approves Differin Gel 0.1% for over-the-counter use to treat acne
8 July 2016 - First retinoid approved for over-the-counter use. ...
Posted by Michael Wonder on 08 Jul 2016
NHS England, PTC reach agreement on Duchenne drug
8 July 2016 - Children in England suffering from a rare form of muscular dystrophy will soon be able to access ...
Posted by Michael Wonder on 08 Jul 2016
European Commission grants marketing authorization for Gilead’s Epclusa (sofosbuvir/velpatasvir) for the treatment of all genotypes of chronic hepatitis C
8 July 2016 - Epclusa is the first and only all-oral, single tablet regimen for all genotypes (1-6) of chronic hepatitis ...